ABSTRACT The mammalian heart is a complex organ composed of diverse components and various cell types. Heart organogenesis requires the contribution of distinct pools of heart progenitors positioned in separate embryonic regions and subject to particular developmental signals. Moreover, these embryonic heart lineages have different transcriptional profiles expressing specific genes which activate pathways involved in heart lineage specification. Understanding the molecular control of heart organogenesis has major implications for treating congenital and adult heart diseases since specific heart lineages have been associated with particular human cardiovascular malformations. Collagen and calcium-binding EGF-like domain 1 (Ccbe1) was identified in our laboratory using an Affymetrix GeneChip system approach to identify the transcriptome of chick heart/hemangioblast precursor cells. Here, we present a detailed and systematic analysis of the expression of Ccbe1 during early mouse development using whole-mount in situ hybridization (WISH), immunohistochemistry and histological techniques. Ccbe1 mRNA was initially detected in the early cardiac progenitors of the two bilateral cardiogenic fields (E7.0) and in the cardiogenic mesoderm (E7.5 to E8.0). Ccbe1 mRNA was then persistently detected in the pericardium and transiently expressed in the myocardial tissue of the primitive heart tube (E8.25), being later expressed in the proepicardium. By E9.5, the Ccbe1 and Prox1 proteins were found to be expressed in common regions, including the septum transversum and in the proximity of the anterior cardinal vein. Here, it is shown that Ccbe1 is expressed in the FHF, SHF and proepicardium during heart organogenesis (E7.0 to E8.75). Later in development, Ccbe1 expression is localized in the septum transversum and in the vicinity of the anterior cardinal vein, embryonic structures related to hepatic and lymphatic development, respectively.
and pancreatic specification (Mommersteeg et al., 2010, Burke and Oliver, 2002) . Almost simultaneously with the epicardium formation, the cardiac neural crest cells migrate from the dorsal neural tube into the heart to give rise to the vascular smooth muscle of the aortic arch, ductus arteriosus and great vessels (Epstein and Buck, 2000) . Understanding the tight spatial and temporal control of differentiation and unravel novel marker genes for these heart cell lineages is critical for a better knowledge of the molecular control of cardiogenesis which in turn has major implications for treating both congenital and adult heart diseases.
We have previously reported a differential screening using Affimetrix GeneChip® Chicken Genome arrays to identify novel genes required for the correct development and differentiation of the vertebrate heart and hemangioblast precursor cell lineages (Bento et al., 2011) . A construct containing EGFP expression under the control of a 2.5 kb fragment upstream the ATG of chick Cerberus (cCer; Tavares et al., 2007) was used to electroporate chick embryos and isolate early cardiac progenitors. The genetic profiling provided relevant data of the chick heart/hemangioblast precursor lineage identity and led to the detection of 301 uncharacterized genes (119 unknown genes and 182 annotated genes) that were upregulated in the heart/hemangioblast precursors in comparison to embryonic control cells (Bento et al., 2011) . Among the annotated genes potentially involved in heart development, chick Collagen and calcium-binding EGF-like domain 1 (cCcbe1) was found to be upregulated by 7.8 fold.
Recently, mouse (m)Ccbe1 has been shown to be essential for budding and/or migration of lymphatic endothelial cells (LECs) from the anterior cardinal veins to form the lymph sacs (E10.5 to E13.5) and give rise to the lymphatic vasculature (Bos et al., 2011) . Indeed, homozygous mCcbe1 knockout mice showed a reduction of the number of Prox-1 + and Lyve-1 + LECs at the level of the cardinal vein and lymph sacs which lead to defective lymphatic vasculature, severe edema and prenatal death (Bos et al., 2011) . In zebrafish, zccbe1 transcripts were also found to be located along the migratory routes of lymphangioblast that bud from the cardinal veins to seed the horizontal myoseptum region and subsequently generate the primordial lymphatic vessels. Moreover, homozygous mutation in the calcium-binding EGF-like domain (exon 4) of zccbe1 gene was shown to result in absence of thoracic duct and longitudinal lymphatic vessels which in turn resulted in severe edema and high lethality rate of mutant fish . In humans, CCBE1 gene has also been associated with Hennekam syndrome, a disorder characterized by abnormal lymphatic system development causing generalized lymphedema, intestinal lymphangiectasias and mild to moderate levels of growth and mental retardation. Homozygous cysteine to serine mutation in a human CCBE1 (hCCBE1) gene region (exon 3) highly conserved across vertebrates has been shown to result in a generalized lymphatic dysplasia leading to significant morbidity and high mortality prevalence (Connell et al., 2009; Alders et al., 2009) . While the importance of mCcbe1 for the development of the lymphatic system appears to be indisputable, its role in cardiac development has not been investigated despite the increasing evidence of a potential function in cardiogenesis. Indeed, analyses of mCcbe1 heterozygous knockout embryos have shown X-Gal staining in the mesothelium of the heart at E12. 5 (Bos et al., 2011) . Furthermore, some of the Hennekam syndrome patients carrying a mutated hCCBE1 gene were shown to possess congenital heart defects including hypertrophic cardiomyopathy and ventricular septal defects (Connell et al., 2009; Alders et al., 2009) .
Here, we report that during early mouse development, mCcbe1 mRNA is initially expressed in the early cardiac progenitors that emerge from the primitive streak to form the two bi-lateral cardiogenic fields at E7.0 and in the cardiogenic mesoderm of the FHF and SHF between E7.5 to E8.0. mCcbe1 mRNA is then expressed in the pericardium and in the primitive heart tube at E8.25 and in the proepicardium, septum transversum and somites between E8.75 and E10.0. In addition, immunohistochemistry demonstrated that mCcbe1 and Prox1 proteins were detected at the level of the septum transversum and in the vicinity of the anterior cardinal vein, a primordial site for the onset of lymphangiogenesis. Adding to the reported role in the development of the lymphatic vasculature, the consistent expression of mCcbe1 in tissues containing the most relevant cardiac progenitor lineages put this gene forward as an important marker of heart precursor cell lineages.
Results
cCcbe1 was identified during a gene expression profiling of chick heart/hemangioblast precursors using Affymetrix ® GeneChip Arrays (Bento et al., 2011) . Gene expression analysis using whole mount in situ hybridization (WISH) confirmed the cCcbe1 is expressed in the early cardiac progenitors of the heart forming region and continue to be expressed in major cardiogenic lineages during chick heart development (unpublished data). In addition, cCcbe1 is also expressed in the anterior and posterior cardinal veins and in the somites (unpublished data). Moreover, Ccbe1 gene is conserved across vertebrates with chick Ccbe1 aminoacid (a.a.) sequence being 79% and 69% identical to the mouse and zebrafish Ccbe1 protein, respectively. In mouse, mCcbe1 encodes a 408 a.a. predicted secreted protein that contains a signal peptide, a collagen domain and a calcium binding EGF-like domain. To characterize the expression of mCcbe1 during mouse development, a blast search was conducted to identify several plasmid clones suitable for synthesis of WISH anti-sense probes. A plasmid DNA clone containing an 854 bp sequence fragment of the 3'UTR of mCcbe1 gene was ordered. Here we present a comprehensive analysis of the expression pattern of mCcbe1 during mouse development (E7.0 to E10.5) with particular focus on the process of morphogenesis and organogenesis of the heart. Overall expression of mCcbe1 was determined by WISH and more detailed analysis of tissue specific expression was examined using histological techniques. Single WISH using probes for the proepicardium marker Tbx18 and double WISH using probes for mCcbe1 and the SHF marker Isl1 were carried out to determine the exact cardiogenic lineages expressing mCcbe1. In addition, immunohistochemistry using antibodies for mCcbe1 and Prox1 was performed to confirm expression of mCcbe1 at the level of the septum transversum and in the domains surrounding the anterior cardinal vein. mCcbe1 expression in the cardiogenic mesoderm mCcbe1 mRNA is firstly detected at E7.0 forming two fields at an anterior-lateral position under the primitive head fold region and on either side of the notochordal plate ( Fig. 1A and 1B, arrows) . Between E7.25 to E7.5, mCcbe1 messages are extended from the initial bi-lateral fields to a more anterior and medial position forming a crescent-like shape under the head folds (Fig. 1C to 1F ). Histological sections demonstrate that mCcbe1 expression is located at the cardiogenic mesoderm subjacent to the head fold ( Fig. 1D' and 1D'' ). At E7.5, mCcbe1 continues to be expressed in the cardiogenic mesoderm that will give rise to the future cardiogenic plate (arrow, Fig. 1F' ) and in the mesothelial cells that give rise to the intra-embryonic coelomic cavity (arrowhead, Fig. 1F '' and 1F'''). At the primitive heart tube stage (E8.0), mCcbe1 mRNA staining continues to generate a well defined crescent-like shape under the head folds (Fig. 1G to 1J ). Expression is located at the cardiogenic plate (arrow, Fig. 1H') and myocardial tissue forming the primitive heart tube and in the mesothelium lining the coelomic cavity (prospective pericardial cavity; arrowhead, Fig. 1H'' ) and the left-and right-horn of the coelomic canals (future left and right pericardio-peritoneal canals; Fig.1H''' ). Moreover, double WISH performed to detect mCcbe1 mRNA (light blue) and Isl1 mRNA (purple) at E8.0 demonstrated that mCcbe1 is mainly expressed in FHF progenitors ( Fig. 1I and 1J ). Nevertheless, less intense mCcbe1 staining was also detected in Isl1 positive regions suggesting that the cardiac progenitors of the SHF also express Ccbe1 ( Fig.  1I and 1J ). Histological sections at the level of the cardiogenic plate shows that Isl1 transcripts are specifically located in the SHF precursors of pharyngeal mesoderm whereas mCcbe1 transcripts are mostly expressed by the FHF progenitors located at a more ventral position (Fig. 1J' ). Sections at a more posterior region, also demonstrate that the most medial limit of mCcbe1 expression in the cardiogenic mesoderm lining the intra-embryonic coelomic cavity (purple arrow, Fig. H ''' and J''') is contained within the Isl1 expression domain (blue arrow, Fig. J''' ). At E8.25, mCcbe1 mRNA was detected in the ventral mesothelium of the pericardium (Fig.  1L ', 1L'', 1N' and 1N'') and mesoderm lining the intra-embryonic coelomic cavity (Fig.1L ''' and 1N'''). Noteworthy, less intense mCcbe1 staining was also detected in the heart tube tissue adjacent to the ventral pericardium (arrows, Fig. 1L' and 1N' ). At this stage, mCcbe1 mRNA continues to be weakly colocalised with Isl1 ( Fig.  1L' and 1N' ). Indeed, staining at the level of the heart tube further relates mCcbe1 with the FHF progenitors.
mCcbe1 expression in the proepicardium
At E8.5, mCcbe1 expression outlines a V-like shape staining that delineates the pericardial cavity and fuse at a posterior position to the heart ( Fig. 2A and 2B ). At this stage of development, mCcbe1 staining localizes in the mesothelium of the pericardial cavity ( Fig.  2B' ). mCcbe1 expression in the heart is residual and most likely restricted to cardiac cells derived from mCcbe1-expressing cardiac (L'',N') , heart tube tissue adjacent to the ventral pericardium (arrows, L' ,N') and mesoderm lining the intra-embryonic coelomic cavity (L''' , N''') 
E,F). A series of transverse sections extending from the head fold level towards to a more caudal positions showed that mCcbe1 is expressed in the cardiogenic plate (arrow in F') and in the mesothelial precursors of the intra-embryonic coelomic cavity (arrow in F'', F'''). Lateral (G) and anterior (H) views of whole mount in situ hybridization at the early heart tube stage (E8.0). Transverse histological section showed mCcbe1 mRNA located in the cardiogenic plate (arrow, H'), myocardial tissue of the primitive heart tube and mesothelium of the pericardial cavity (arrow, H'') and in the left-and right-horn of the coelomic canals corresponding to the prospective left and right pericardio-peritoneal canals (arrow, H'''
progenitors that have not yet completely downregulated mCcbe1 expression (Fig. 2B') . Moreover, cross sections of E8.5 embryos at the level of the sinus venosus demonstrated the presence of two clusters of mCcbe1-expressing cells that are continuous with the pericardial cavity and most likely compose the right and left anlagen of the developing proepicardium (arrows, Fig. 2B'' ). Indeed, in mouse, the proepicardium is derived from two anlagen of pericardial mesothelium which appear on either side of the venous pole of the pericardial cavity at E8.5. These cells then migrate to the embryonic midline where they merge to give rise to the mature proepicardium at E9.0 (Manner et al., 2001 , Mommersteeg et al., 2010 . Indeed, transverse sections of embryos between E8.5 and E8.75 at the level of the sinus venosus showed that mCcbe1 has a wide expression extending laterality from the cells adjacent to the right horn to the cells adjacent to the left horn of the sinus venosus ( Fig. 2D'' and 2E'). Moreover, histological sections of double WISH performed to detect mCcbe1 mRNA (light blue) and Isl1 mRNA (purple) revealed that mCcbe1 staining is partially overlapped with Isl1 staining at the level of the primitive proepicardium (arrows, Fig.1D ''). In addition, mCcbe1 mRNA staining is also detected in the dorsal-lateral side of the mesothelium of the right and left pericardio-peritoneal canal where Isl1 is also expressed (arrows, Fig. 2B ''' and 2D'''). However, no co-localization of Isl1 and mCcbe1 were detected at the level of the pharyngeal mesoderm (Fig. 1D') . To further confirm that mCcbe1 expression at the level of the venous pole of the heart is related to the proepicardium organ, mCcbe1 and Tbx18 mRNA expression was compared in littermate embryos. Indeed, analysis of whole mount embryos and sagital sections clearly demonstrate that mCcbe1 and Tbx18 expression coincide at the level of the proepicardium (Fig. 2F to 2F''' and 2G to 2H'''). Later in development, at E9.5, mCcbe1 expression is maintained in the proepicardium (Fig. 3A to 3C ). Histological analysis of transverse and sagital sections confirm that the expression of mCcbe1 is residual or non-existent in the heart components ( Fig. 3B' ) but rather strongly expressed in the heart progenitors of the proepicardium (arrowheads, Fig 3B' ', 3B''', 3C'' and 3C'''). In addition, transverse sections of E9.5 embryos stained for mCcbe1 or Tbx18 mRNA at the level of the hepatic diverticulum (region of foregut-midgut junction) showed that mCcbe1 expression encompasses a region wider than the Tbx18 expression and extends towards the septum transversum (Fig. 3B''' and 3E''' ). To confirm that mCcbe1 expression at the level of the hepatic diverticulum was not only restricted to the proepicardium but also present in the septum transversum, immunohistochemistry for mCcbe1 and the septum transversum marker Prox1 was carried out in histological sections (Fig. 4) . Indeed, mCcbe1 protein was detected in the extracellular domain of some Prox1 + cells. However, mCcbe1 was not detected in the extracellular domain of all Prox1
+ cells but rather more concentrated around the more central Prox1 + cells of the septum transversum (Fig. 4B ). In addition, histological sections at the interface between the septum transversum and the embryonic gut shows high levels of mCcbe1 protein localized around the Prox1 + cells and lower levels of mCcbe1 protein within the lumen of the gut (Fig. 4C) . Expression of mCcbe1 in both the proepicardium and the septum transversum is consistent with the fact that these two transient organs are in close contact with each other and derive from adjacent progenitor (F'' and F''') 
and Tbx18 (H'', H''') expression is located in a region posterior to the venous pole of the heart corresponding to a more visceral region of the proepicardium. Scale bars, 200 mm.
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regions at the lateral zone of the cardiogenic mesoderm (lateral rim of the splanchnic mesoderm; Mommersteeg et al., 2010, Burke and Oliver, 2002) . Moreover, expression of mCcbe1 at the septum transversum is consistent with the previous expression at the right and left pericardio-peritoneal canals at E8.5 ( Fig.2B''' ) as the septum transversum derives from the fusion of the left and right pericardio-peritoneal to individualize the pericardial and peritoneal cavities. At E10.5, expression of mCcbe1 is then maintained at the mesothelium of the pericardial cavity and in the septum transversum ( Fig. 3F to 3G '''). However, expression of mCcbe1 in the septum transversum at this stage of development is restricted to a small number of cells (arrow, Fig. 3G'' ). Downregulation of mCcbe1 at the level of proepicardium and septum transversum at this stage of development is coincident with the major translocation of cardiac progenitors from proepicardium to the heart and subsequent fading of the transient proepicardium organ (Zhou et al., 2008) .
Ccbe1 expression in non-cardiogenic regions
Apart from the consistent expression of mCcbe1 in cardiac progenitor tissues, mCcbe1 mRNA was also detected in the subset of cells located in a dorsal position to the heart, and the proepicardium of the mouse embryo at E9.5 (arrow, Fig. 3B and 3C ). Transverse and sagital sections demonstrate that mCcbe1 mRNA staining is located in the vicinity of the anterior cardinal vein (arrow, Fig. 3B ''and 3C'). Indeed, mCcbe1 expression in embryonic tissues close to the anterior cardinal veins has recently been demonstrated using X-gal staining of heterozygous mCcbe1 knockout embryos (Bos et al., 2011) . In addition, double immunohistochemistry analysis detected mCcbe1 protein and Prox1 + cells in vicinity of the anterior cardinal vein (yellow arrows, Fig. 4A ). These Prox1 + cells represent LECs that bud from the anterior cardinal vein to give rise to the lymph sacs and the primordial lymphatic system (Bos et al., 2011) . Here, it is reported that mCcbe1 protein is expressed in the tissues surrounding the anterior cardinal vein where Prox1 + LECs are also present. mCcbe1 expression was also detected in the head mesenchyme between E8.25 and E8.75 (Fig. 1L, 2B and 2F') and dermomyotome of somites between E9.5 and E10.5 ( Fig. 3B ''' and 3G''''). Interestingly, expression of mCcbe1 at level of the somites appears to be much more intense in the cervical somites than in the anterior occipital or posterior thoracic somites (Fig. 3A and 3F ) suggesting that mCcbe1 mRNA is possibly upregulated during a specific stage of somite maturation or otherwise more particularly involved in cervical somite differentiation. On the other hand, Flk1, a marker of endothelial and hematopoietic progenitors, is also expressed in the somites and in the cardiogenic mesoderm precursors and has been shown to 
Lateral view of E9.5 embryo showed that mCcbe1 is expressed in the proepicardium, in the anterior cardinal veins (arrow) and in the somites (A,B). Transverse sections show that mCcbe1 expression in the heart is residual or non-existent (B') but rather highly expressed in the proepicardium (arrowhead; B'', B'''), in the anterior cardinal vein (arrow; B'', B''') and dermomyotome of the cervical somites (B'', B'''). Sagital sections further demonstrate that mCcbe1 staining is located in the vicinity of the anterior cardinal vein (arrow) which during mouse development gives rise to important veins of the cardiovascular and lymphatic systems (C). Comparative analysis of whole mount and histological sections of littermate embryos processed to detect mCcbe1 (A to B''') and Tbx18 mRNA (D, E) showed that mCcbe1 expression is mostly coincident with Tbx18 expression (B''', E'''). A lateral view of a mouse embryo stained for mCcbe1 mRNA at E10.5 (F,G). Transverse sections showed that mCcbe1 is expressed at the maxilary component of the first branchial arch containing trigeminal (V) neural crest tissue (G'), in the mesothelium of the pericardium and in a restricted region of the septum transversum (arrow; G'') and in the dermomyotome of the somites (G''''). Scale bars, 200 mm.
contribute to the cardiac muscle cell lineages (Ema et al., 2006; Motoike et al., 2003) . In addition, mCcbe1 is also expressed at the maxilary component of the first branchial arch containing trigeminal (V) neural crest tissue (arrow, Fig. 3F and 3G ) and at the second branchial arch cleft at E10.5 (arrowhead, Fig. 3F and 3G ).
Discussion
Expression analysis showed that mCcbe1 mRNA was initially
detected at an anterior-lateral position on either side of the notochordal plate at E7.0 (arrow, Fig. 1B ). mCcbe1 mRNA staining at this stage of development coincides with the commitment of mesodermal cells that emerge from the anterior region of the primitive streak to form two bilateral fields with cardiogenic potential. Although, cardiac progenitors have been mapped at the anterior region of the streak, these cells retain a certain level of plasticity and become much clearly committed to cardiac fate upon migration into an anterior-lateral direction to form two groups of cells on either side of the midline (Tam et al., 1997) . During E7.25 to E8.0, expression of mCcbe1 mRNA forms a crescent like-shape at the cranial and cranial-lateral regions of the embryo resembling that observed in staining performed using markers of the FHF and SHF such as Hand1 and Isl1, respectively (Cai et al., 2003, Biben and Harvey, 1997) . Indeed, histological section showed that mCcbe1 is expressed in the cardiogenic mesoderm ( Fig. 1D ' and 1F'') and subsequently in the cardiogenic plate (arrow, Fig. 1H ') as well as in the mesothelial cells of the intra-embryonic coelomic cavity that later gives rise to the pericardial cavity and pericardio-peritoneal canals where mCcbe1 is also expressed (Fig. 1H'' ', 1J''' and 1L'''). Moreover, double WISH showed that mCcbe1 is mainly expressed in the FHF although low levels of mCcbe1 mRNA were also detected in the Isl1 positive SHF (Fig. 1J ' to 1J''' and 1N' to 1N'''). Although, mCcbe1-expressing cells could be detected in the myocardial tissue forming the primordia of the primitive heart tube at E8.0 (arrows, Fig 1H'' and 1N') , expression in the cardiac tissue in more advanced stages of heart morphogenesis was residual or nonexistent (Fig. 2B') . Continuous expression of mCcbe1 in the cardiogenic mesoderm and residual levels in the primordial myocardial tistected in the proximity of the anterior cardinal vein (arrow, Fig. 3B and 3C). Expression of mCcbe1 at the level of the cardinal veins have previously been reported in mouse at E10.5 and E12.5 using X-gal staining of mCcbe1 knockout embryos (Bos et al., 2011) and in zebrafish at 36 h to 48 h post fertilization (hpf) using WISH ). In addition, mCcbe1 knockout embryos and zccbe1 mutant zebrafish have been shown to have a highly defective lymphatic system which accounts for a generalized edema and ultimately to premature death Bos et al., 2011) . Adding to this, here we demonstrate that mCcbe1 protein was detected in the extracellular domain of tissues containing Prox1 + LECs at the level of the anterior cardinal vein (yellow arrows, Fig. 4A) . Moreover, the detection of mCcbe1 protein near Prox1 + LECs further supports the previously raised hypothesis that Ccbe1 protein might act as an extracellular guidance molecule regulating the budding and migration of lymphangioblasts from the anterior cardinal vein . In humans, homozygous and compound heterozygous mutations of hCCBE1 gene have also been shown to result in generalized lymphatic dysplasia associated with the very debilitating and highly deadly Hennekam syndrome (Connell et al., 2009; Alders et al., 2009 ). Despite the above mentioned and more preeminent defects in sues followed by absence of expression at later stages of heart development suggests that expression of mCcbe1 is limited to multipotent and highly proliferative progenitors and downregulated upon cellular commitment into more specific cardiac phenotypes. Indeed, restricted expression in the primordia of the heart tube is possibly limited to a subset of cardiac cells that derived from mCcbe1-expressing cardiac progenitors that have not yet completely downregulated mCcbe1 expression.
Later in development, mCcbe1-expressing cells were located at the developing and mature proepicardium and septum transversum (arrows, Fig. 2B '', 3E', 4B and 4C). As previously described, these two populations arise from adjacent progenitor regions but contribute to the development of different organs. The proepicardium cells arise from Nkx2.5
+ progenitors at the lateral zone of the cardiogenic mesoderm (lateral rim of the splanchnic mesoderm; Zhou et al., 2008; Mommersteeg et al., 2010) and originates the epicardium, the majority of the cardiac interstitium, and the coronary vasculature (Poelmann et al., 2002) whereas the septum transversum can be identified through the expression of Prox1 (Fig. 4B and 4C ) and is involved in hepatic and pancreatic development (Burke and Oliver, 2002) .
During E9.5 to E10.5, mCcbe1-expressing cells were also de-
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lymphangiogenesis, cysteine to serine mutation of hCCBE1 gene (C75S) has also been shown to be associated with in hypertrofic cardiomyopathy and congenital heart defects (Connell et al., 2009; Alders et al., 2009) . This raises the possibility of a role of Ccbe1 in the organogenesis of the heart from cardiac progenitors of the FHF, SHF and proepicardium where mCcbe1 is now reported to be expressed. Demonstration of a role in heart organogenesis must wait for further studies on genetic interactions of mCcbe1 with other genes involved in cardiac development.
In conclusion, we presented a comprehensive analysis of mCcbe1 expression during early mouse development. mCcbe1 was shown to be expressed in three major populations of embryonic cardiac progenitors namely the FHF, SHF and proepicardium. Moreover, mCcbe1 was expressed in these cardiogenic regions but rather not expressed in their derivative and more mature heart components suggesting that Ccbe1 is downregulated as the progenitor cells differentiate towards more definitive cardiac phenotypes. As such, mCcbe1 appear to be an exclusive and common marker of cardiac precursors of the FHF, SHF and proepicardium. Despite the role of Ccbe1 on the onset of lymphangiogenesis being irrefutable, the potential involvement of Ccbe1 in heart morphogenesis still needs to be investigated.
Materials and Methods
A gene expression profiling of chick heart/hemangioblats precursors followed by a protocol for direct amplification of small amounts of mRNA (Gonçalves et al., 2011) and GeneChip Arrays (Affymetrix ®) has been recently reported (Bento et al., 2011) . Among the genes identified, cCcbe1 mRNA was found to be upregulated in the heart/hemangioblast gene pool being therefore potentially required for vertebrate heart development.
Embryo collection
C57BL/6 mice were maintained on a 7pm to 7am dark cycle and mated overnight. Mouse embryos were obtained by crossing C57BL/6 mice and embryonic development was staged according to gestational age, with noon of the day of vaginal plug detection being considered E0.5. Pregnant females were sacrificed by cervical dislocation and the uteri were surgically removed and placed in ice-cold PBS. Embryos were dissected out of the decidua with fine forceps as previously described (Hogan et al., 1994) and staged according to morphological landmarks (Downs and Davies, 1993) .
Whole mount in situ hybridization and histological analysis
WISH and anti-sense probe preparation was carried out as described in Belo et al., (1997) . Briefly, dissected embryos at various stages of development (E7.0 to E10.5) were fixed overnight at 4°C in 4% paraformaldehyde, dehydrated through a graded methanol series and stored at -20°C until use. WISH was repeated at least 3 times for each developmental stage using an entire litter in each experiment (minimum of 6 embryos per litter (n=18)). Digoxigenin-labeled mCcbe1 anti-sense RNA probe was synthesized by linearizing the RZPDp981D0934D clone (mCcbe1; ImaGenes, Berlin, Germany) with EcoRI restriction enzyme and transcribed using T3 RNA polymerase. The RZPDp981D0934D plasmid clone encodes an 854 bp fragment of the 3'UTR of mCcbe1 gene. Digoxigenin-labeled Tbx18 anti-sense RNA probe was synthesized by linearizing the pKS-Tbx18 clone with HindIII restriction enzyme and transcribed using T7 RNA polymerase. The fluorescein-labeled Isl1 anti-sense RNA probe was synthesized to perform two-color double WISH staining. Isl1 plasmid clone was linearized using XhoI restriction enzyme and transcribed using T3 RNA polymerase. The anti-sense probes were run on a 2% agarose gel to verify yield and length. Double staining was performed by simultaneous hybridization of digoxigenin-labeled mCcbe1 anti-sense RNA probe and the fluoresceinlabeled Isl1 anti-sense RNA probe. Embryos were initially incubated with the alkaline phosphatase (AP)-conjugated anti-DIG Fab antibody (Roche Applied Sciences, Penzberg, Germany) overnight at 4°C. After several washes, specimens were incubated with AP-substrate BM purple solution (NBT/BCIP ready-to-use solution; Roche) and allowed to develop through chromogenic reaction to detect Ccbe1 mRNA expression. Following thorough staining, AP enzymes were inactivated through a 72u61904C incubation in MABT (100mM Maleic Acid; 150mM NaCl; 0.1% Tween 20, pH7.5) for 1 hour. Samples were then incubated overnight at 4°C with the AP-conjugated anti-fluorescein Fab antibodies (Roche). After another series of washes, a solution containing the AP-substrate BCIP (187.5 mg/ ml; Roche) was used to perform staining of the fluorescein-labeled probe. Finally, embryos were refixed in 4% paraformaldehyde and photographed using a Lumar V12 stereoscope and the Axiocam MRC digital camera (Carl Zeiss). Embryos selected for histological analysis (minimum of 4 embryos per developmental stage (n=4)) were embedded in paraffin and sectioned at 8 mm using a Leica RM2135 microtome. The sections were examined and photographed using a Axio Observer Z2 Fluorescence microscope (Carl Zeiss) and the digital camera AxioCam ICc 3.
Immunohistochemistry
Mouse embryos (E9.5) were dissected as described above, embedded in OCT (Tissue Tek, Torrance, CA) and frozen overnight at -80u61904C. Cryosections were cut at 10 mm using a Leica C3050 cryostat microtome (Leica Microsystems, Wetzlar, Germany), mounted onto superfrost slides and stored at −80°C until use. After thawing, the slides were fixed in 1% paraformaldehyde in PBS for 2 minute and washed in 0.1% Tween in PBS (PBS-T). The sections were then incubated in blocking solution (0.2% BSA (Roche Diagnostics, Mannheim, Germany) PBS-T) for 1 hour. Primary antibody incubations were performed overnight at 4u61904C using 1.5 mg/mL of the Ccbe1 anti-mouse antibody (Sigma-Aldrich, Sintra, Portugal) diluted in blocking solution in combination with 2 mg/mL of the Prox1 antigoat antibody (R&D systems, Minneapolis, MN). The sections were then washed three times in PBS-T for 5 minutes and incubated for 1 hour at RT with 2 mg/mL AlexaFluor-488 donkey anti-goat antibody (Molecular probes, Paisley, UK) and 2 mg/mL AlexaFluor-594 donkey anti-mouse antibody (Molecular Probes) diluted in blocking solution. Control experiments were performed using no primary antibodies against mCcbe1 or Prox1 but using the secondary antibodies at the corresponding concentrations. The sections were further washed three times with PBS-T for 5 minutes and placed onto slides using mounting medium containing DAPI (Vectashield; Vector Labs, Peterborough, England). Confocal fluorescent microscopy was performed using the laser scanning microscope LSM710 Confocal microscope (Carl Zeiss) and images captured using the Zen 2009 software at 100x, 200x and 400x magnification. A minimum of 3 embryos were analyzed by immunohistochemistry in 2 separate experiments (n=6)). Negative controls were used to determine the appropriate exposure time and prevent the generation of false positives in the samples.
